J7674 – Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7674
- Long description
- Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
- Short description
- Methacholine chloride, neb
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2005
- Last change
- January 1, 2005 – No change
Frequently asked questions
What is HCPCS code J7674?
J7674 is a HCPCS Level II code for methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg.
Does Medicare cover J7674?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7658 – Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
- J7659 – Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7660 – Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7665 – Mannitol, administered through an inhaler, 5 mg
- J7667 – Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
- J7668 – Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
- J7669 – Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7670 – Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7676 – Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
- J7677 – Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
- J7680 – Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7681 – Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7682 – Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
- J7683 – Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7684 – Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7685 – Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.